4:32
Behind the Study: DLL3, ASC1, TTF-1 & Ki-67 in Precision Medicine for SCLC | Oncotarget
Oncotarget
6:16
Behind the Study: Molecular Chaperones & Tumor Suppressor Stability | Oncotarget
6:47
Behind the Study: Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167 | Oncotarget
8:15
Osteopontin Induces Mitochondrial Biogenesis in Deadherent Cancer Cells | Oncotarget
8:49
HER3: A Vital Target in Cancer Treatment | Oncotarget
5:07
ER Expression Multiclonality in DCIS: Clinical & Future Insights | Oncotarget
7:00
Behind the Study: Molecular Dialogue Between Tumor Cells and Fibroblasts | Oncotarget
3:07
Role of Biomarkers in Management of Lumps in the Breast | Oncotarget
7:50
APOE Genotype & Exercise Benefits in Cancer Patients | Oncotarget
9:23
Inhibition of Resistant Triple-negative Breast Cancer Cells | Oncotarget
8:23
Targeting Lipid Metabolism in the Treatment of Ovarian Cancer | Oncotarget
5:47
Molecular Characterization of Lung Carcinomas Expressing KK-LC-1 | Oncotarget
4:38
IGF-pathway Biomarkers and Lung Cancer | Oncotarget
10:39
Mitigating Radiation for Space Colonization | Oncotarget
9:08
A Potential Protective Mechanism Against UVB Exposure | Oncotarget
7:59
Cancer Drug Prices in Low- and Middle-Income Countries | Oncotarget
13:48
Oncotarget | Precision Oncology Improves Patient Survival and Financial Burdens
7:21
Oncotarget | Role of Cancer Associated Fibroblasts in Prostate Cancer
12:47
Oncotarget | Rare Incidence of Type 1 Diabetes Induced by Immunotherapy
17:24
Oncotarget | Microbial Metabolite Mimicry May Improve Drug Discovery
25:42
Oncotarget | Zebrafish B Cell Acute Lymphoblastic Leukemia: New Findings in Old Model
8:39
Oncotarget | CrkL Required for Donor T Cell Migration to GvHD Target Organs
6:46
Oncotarget | Innovating & Expanding Weight Loss Strategies for Breast Cancer Survivors
11:42
Oncotarget | Reversing Oncogenic Transformation With Iron Chelation
11:26
Oncotarget | Functional Inhibitor Compounds Inhibit Herpes Simplex Virus Proliferation
6:49
Oncotarget | Unique Biomarker Analysis & Interpretation Platform in Clinical Decision-making
5:09
Oncotarget | GATA3 and APOBEC3B are Prognostic Markers in Adrenocortical Carcinoma
8:21
Oncotarget | Prolyl 4-hydroxylase Alpha 1 Protein and Early Stage Colorectal Cancer
6:21
Oncotarget | Exploratory Study of Metformin and Rapamycin as Maintenance Therapy
Oncotarget | Genomic and Neoantigen Evolution in Head and Neck Squamous Cell Carcinoma
15:51
Oncotarget | Consuming Cholera Toxin Counteracts Age-associated Obesity
9:04
Oncotarget: Benzophenone-3 Promotion of Mammary Tumorigenesis is Diet-dependent
19:30
Oncotarget: Epigenetic feedback and stochastic partitioning can drive resistance to EMT
19:20
Oncotarget: Evaluations in the TRAMP prostate cancer model
16:06
Oncotarget: Epithelial-mesenchymal transitions create endothelial cells & tumor growth
15:17
Oncotarget: Retaining nanomolar potency in lung cancer with therapy-refractory mutations
29:39
Oncotarget: Breast cancer cells to ONC201 from anti-proliferative to apoptotic
LIVE
[Private video]
8:10
Oncotarget: Melatonin increases overall survival of prostate cancer patients
29:15
Oncotarget: Novel insights into the prognostic evaluation of prostate cancer
15:47
Oncotarget: Cancer Stem Cells and Macrophages against Cancer
11:52
Oncotarget | The critical role that STAT3 plays in glioma-initiating cells STAT3 addiction in glioma
16:22
Oncotarget | Statins affect human glioblastoma and other cancers through TGF-β inhibition
7:07
Oncotarget | Findings offer new clues for targeting drug resistant colon cancers
6:08
Down Syndrome iPSC Model: Endothelial Perspective on Tumor Development | Oncotarget
Secretomes from Metastatic Breast Cancer Cells and MSC Actions | Oncotarget
12:54
Oncotarget: ONC201 kills breast cancer cells in vitro by targeting mitochondria
9:09
Oncotarget: Empty SV40 capsids elicit host signaling networks
6:58
Oncotarget: Survival in patients with lung adenocarcinoma harboring "niche" mutations
11:17
Oncotarget: Metronomic cyclophosphamide - innate immunity and anti-tumor responses
10:51
Oncotarget: Phenanthrene exclusively eradicates human pancreatic cancer cells in xenografts
11:32
University of Vermont Cancer Center's Marie Wood talks about their publication in Oncotarget
4:45
Oncotarget: Dendritic cell sarcoma & rapid research autopsy
28:49
Oncotarget: Anti-psychotic drug could treat aggressive breast cancer
4:31
Oncotarget: Wnt signaling perturbs spermatogenesis
6:25
University of Texas Medical School's Dr. Anutosh Ganguly talks about his Publication in Oncotarget
Oncotarget: Prognostic role of elevated mir-24-3p in breast cancer
10:00
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
6:44
Oncotarget: A procaspase-3 activator and temozolomide extends survival in glioma models
Oncotarget: Molecular trigger for invasiveness in prostate cancer cells
7:24
Oncotarget: Researchers identify potential therapeutic target in aggressive breast cancer cells
7:58
Oncotarget: Inhibit oral squamous carcinoma cell migration and viability
7:35
Oncotarget: Therapeutic strategy for drug-resistant thyroid cancers
4:56
Oncotarget: LINC00520 is induced by Src, STAT3, and PI3K in breast cancer
6:34
Oncotarget | Interview with Dr. Fon Tacer
5:35
Oncotarget: PRAME associated with increased metastatic risk
4:20
Geisel School of Medicine's and University of Texas's Dr. Dmitrovsky talks with Oncotarget
7:05
Oncotarget: Molecular signatures of chronic degeneration of shoulder muscles
11:36
Oncotarget: Significant differences in biomarker expression in pancreatic cancer
Oncotarget: p53 knockdown to promote malignant peripheral nerve sheath tumor formation
9:03
Oncotarget: BMP9/ALK1 inhibits neovascularization
2:45
Memorial Sloan Kettering Cancer Center's Dr. Hechtman talks about her Publication in Oncotarget
5:25
Dr. Chesler from The Institute of Cancer Research's & The Royal Marsden NHS Trust in Oncotarget
2:50
Oncotarget: Llgl1 prevents metaplastic survival
5:24
The Netherlands Cancer Institute's Dr. Bernards & Diede Brunen talk with Oncotarget
11:05
Oncotarget: Metabolic reprogramming of glioblastoma cells sensitizes for apoptosis
13:04
Oncotarget: PIP3-binding proteins promote limit survival in C. elegans
6:52
Oncotarget: Targeting mesothelin with high cytotoxic activity
7:54
Oncotarget: Transcription and proliferation of human tumor cells
11:50
Oncotarget: PRG3 induces Ras-dependent oncogenic cooperation in gliomas
4:40
Oncotarget: Oncogene inactivation-induced apoptosis in acute lymphoblastic leukemia
7:39
Oncotarget: Camptothecin targets WRN protein: in clinical breast cancer
3:41
Dr. David Loeb, Pediatric Oncologist Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2:06
Oncotarget | Interview with Dr. Pradeep Tanwar, University of Newcastle
Oncotarget: AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis
4:13
Oncotarget: BHD Symposium & International Upstate Kidney Cancer Symposium
2:31
Oncotarget: Cis-acting elements in 3′ UTR mediate post-transcriptional regulation of KRAS
